Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “R-CHOP Chemotherapy”

73 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 73 results

Early research (Phase 1)Study completedNCT00644124
What this trial is testing

Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Sanofi 25
Large-scale testing (Phase 3)UnknownNCT00209222
What this trial is testing

Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL

Who this might be right for
Lymphoma, Mantle-Cell
European Mantle Cell Lymphoma Network 360
Testing effectiveness (Phase 2)UnknownNCT01181999
What this trial is testing

Rituximab Augmentation Following R-CHOP Induction Chemotherapy in Extremely Elderly Patients With Diffuse Large B Cell Lymphoma

Who this might be right for
Lymphoma, Large B-cell, Diffuse
Chonnam National University Hospital 50
Testing effectiveness (Phase 2)Study completedNCT01054781
What this trial is testing

Intensified 1st Cycle Rituximab Plus 8th Cycles of R-CHOP Chemotherapy in Patients With Advanced or Bulky CD20+ Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)
Samsung Medical Center 91
Testing effectiveness (Phase 2)Ended earlyNCT00906841
What this trial is testing

Study of 90Y-DOTA-hLL2 as a Consolidation Therapy After R-CHOP in Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
B-cell Lymphoma
French Innovative Leukemia Organisation 75
Large-scale testing (Phase 3)Study completedNCT02268045
What this trial is testing

Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
mAbxience Research S.L. 272
Not applicableStudy completedNCT00530179
What this trial is testing

FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
AHS Cancer Control Alberta 69
Early research (Phase 1)Study completedNCT03742258
What this trial is testing

Combination Chemotherapy and TAK-659 as Front-Line Treatment in Treating Patients With High-Risk Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma Activated B-Cell TypeDiffuse Large B-Cell Lymphoma Germinal Center B-Cell Type+4 more
Northwestern University 12
Testing effectiveness (Phase 2)Study completedNCT01157988
What this trial is testing

90Y-ibritumomab Tiuxetan Consolidation After 6th R-CHOP Chemotherapy in Patients With Bulky Diffuse Large B Cell Lymphoma

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Chonnam National University Hospital 20
Not applicableEnded earlyNCT01724294
What this trial is testing

An Observational Study of MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in First-Line in Patients With Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Hoffmann-La Roche 113
Testing effectiveness (Phase 2)UnknownNCT04263584
What this trial is testing

Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
University Hospital Muenster 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT01856192
What this trial is testing

Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma

Who this might be right for
Ann Arbor Stage II Diffuse Large B-Cell LymphomaAnn Arbor Stage III Diffuse Large B-Cell LymphomaAnn Arbor Stage IV Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI) 349
Testing effectiveness (Phase 2)Study completedNCT02055820
What this trial is testing

A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCL

Who this might be right for
Lymphoma, Non-Hodgkin
Hoffmann-La Roche 267
Large-scale testing (Phase 3)Study completedNCT01324596
What this trial is testing

A Randomised Evaluation of Molecular Guided Therapy for Diffuse Large B-cell Lymphoma With Bortezomib

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
University Hospital Southampton NHS Foundation Trust 1,132
Large-scale testing (Phase 3)Active Not RecruitingNCT06356129
What this trial is testing

Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma

Who this might be right for
Large B-cell Lymphoma
Celgene 850
Testing effectiveness (Phase 2)Study completedNCT00376961
What this trial is testing

S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 68
Testing effectiveness (Phase 2)Study completedNCT00971763
What this trial is testing

Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma
University College, London 62
Testing effectiveness (Phase 2)Temporarily pausedNCT03704714
What this trial is testing

Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma

Who this might be right for
Aggressive Non-Hodgkin LymphomaB-Cell Non-Hodgkin LymphomaCD20 Positive+5 more
Northwestern University 30
Testing effectiveness (Phase 2)Study completedNCT00117897
What this trial is testing

Treatment for Subjects With Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Amgen
Testing effectiveness (Phase 2)Study completedNCT00290667
What this trial is testing

Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma

Who this might be right for
Lymphoma
German High-Grade Non-Hodgkin's Lymphoma Study Group 586
Load More Results